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Abstract
Background: A treatment to remove vascular blockages, angioplasty, can cause damage to the vessel wall and a
subsequent abnormal wound healing response, known as restenosis. Vascular smooth muscle cells (VSMC) lining
the vessel wall respond to growth factors and other stimuli released by injured cells. However, the extracellular
matrix (ECM) may differentially modulate VSMC responses to these growth factors, such as proliferation,
migration and adhesion. Our previous reports of low-level expression of one ECM molecule, laminin-5, in normal
and injured vessels suggest that laminin-5, in addition to growth factors, may mediate VSMC response following
vascular injury. To elucidate VSMC response on laminin-5 we investigated-the role of platelet-derived growth
factor (PDGF-BB) in activating the mitogen-activated protein kinase (MAPK) signaling cascade as a possible link
between growth-factor initiated phenotypic changes in vitro and the ECM.
Results: Using a system of in vitro assays we assessed rat vascular smooth muscle cell (rVSMC) responses plated
on laminin-5 to the addition of exogenous, soluble PDGF-BB. Our results indicate that although laminin-5 induces
haptotactic migration of rVSMC, the addition of PDGF-BB significantly increases rVSMC migration on laminin-5,
which is inhibited in a dose-dependent manner by the MAPK inhibitor, PD98059, and transforming growth factor
(TGF-β1). In addition, PDGF-BB greatly reduces rVSMC adhesion to laminin-5, an effect that is reversible by
MAPK inhibition or the addition of TGF-β1. In addition, this reduction in adhesion is less significant on another
ECM substrate, fibronectin and is reversible using TGF-β1 but not MAPK inhibition. PDGF-BB also strongly
increased rVSMC proliferation on laminin-5, but had no effect on rVSMC plated on fibronectin. Finally, plating
rVSMC on laminin-5 did not induce an increase in MAPK activation, while plating on fibronectin or the addition
of soluble PDGF-BB did.
Conclusion: These results suggest that rVSMC binding to laminin-5 activates integrin-dependent intracellular
signaling cascades that are different from those of fibronectin or PDGF-BB, causing rVSMC to respond more
acutely to the inhibition of MAPK. In contrast, our results suggest that fibronectin and PDGF-BB may activate
parallel, reinforcing intracellular signaling cascades that converge in the activation of MAPK and are therefore less
sensitive to MAPK inhibition. These results suggest a partial mechanism to explain the regulation of rVSMC
behaviors, including migration, adhesion, and proliferation that may be responsible for the progression of
restenosis.
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Background
Angioplasty is a procedure designed to treat vascular sten-
osis, blockage(s), or atherosclerotic lesions, but it may
also, simultaneously, cause damage to the integrity of the
blood vessel wall. Restenosis is the subsequent narrowing
and occlusion of the blood vessel in response to the injury
or damage sustained during angioplastic procedures such
as balloon dilation [1]. During restenosis, vascular
smooth muscle cells (VSMC) from the injured blood ves-
sel wall migrate into the lumen of the vessel, creating a
new or neointima. The subsequent proliferation of these
neointimal VSMC can lead to a thickening of this neointi-
mal layer and re-occlusion of the vessel [1].
The characteristic response of VSMC, endothelial cells,
platelets, and macrophages at the site of injury is the
release of specific soluble growth factors which include
platelet-derived growth factor (PDGF), transforming
growth factor (TGF), basic fibroblast growth factor
(bFGF), and epidermal growth factor (EGF) [2-4]. VSMC
of the vessel wall respond to these factors by secreting pro-
teolytic matrix metalloproteinases that degrade the extra-
cellular matrix (ECM) and stimulate deposition of new
ECM proteins such as collagen, elastin, fibronectin, and
laminin in the neointima [5-7]. These ECM modulate
VSMC integrin-dependent behaviors such as transluminal
migration, adhesion, and proliferation [8-10].
To date, the precise molecular mechanisms that link
growth factor-initiated intracellular signaling to ECM-
mediated adhesion, migration, and proliferation of VSMC
are still unknown. Our previous reports of low-level lam-
inin-5 expression in the intima of normal vasculature and
an increased expression of laminin-5 in the neointima of
injured vessels suggest that laminin-5, in addition to
PDGF and TGF, may mediate VSMC responsiveness fol-
lowing vascular injury [11-13].
To further elucidate VSMC response to growth factors and
the intracellular signaling cascades that may be linked to
ECM-mediated adhesion, we used in vitro assays to study
the role of laminin-5 in modulating these behaviors in rat
vascular smooth muscle cells (rVSMC). We report here
that PDGF induces differential responses in rVSMC behav-
iors on laminin-5, but not on fibronectin. In addition, we
find that the PDGF-induced responses on laminin-5 are
inhibited in a dose-dependent manner by an inhibitor of
the mitogen-activated protein kinase (MAPK) pathway,
PD98059, but not on fibronectin.
These differences in MAPK-sensitive rVSMC responses in
vitro may be the result of different signaling pathways that
are initiated by integrin-mediated adhesion to laminin-5.
We suggest that rVSMC binding to laminin-5 may initially
activate a MAPK-independent signaling cascade that may
make these cells more responsive to MAPK inhibition. In
contrast, rVSMC binding to fibronectin may activate a sig-
naling pathway shared by PDGF that ultimately converges
in MAPK activation. These results suggest that a complex
interaction of ECM and growth factors may closely regu-
late VSMC behavior following vascular injury and these
studies may directly identify define molecular targets that
may reduce the incidence of restenosis following
angioplasty.
Results
Migration
We have previously reported that laminin-5 expression by
rat vascular smooth muscle cells (rVSMC) is upregulated
by platelet-derived growth factor (PDGF-BB) and that
laminin-5 specifically enhances PDGF-BB-stimulated
rVSMC migration [12]. In addition, our previous results
suggested that PD98059 (a specific inhibitor of MEK and
a general inhibitor of the mitogen-activated protein
kinase ERK1/2 pathway) blocked PDGF-BB-stimulated
migration on laminin-5 [13]. The current study character-
izes this synergistic relationship between PDGF-BB and
laminin-5 in the modulation of rVSMC cell behaviors,
including migration.
The level of rVSMC migration was observed over 18 hours
in transwell migration filters in the presence or absence of
laminin-5, with and without PDGF-BB or serum. Maximal
cell migration (chemotaxis) was obtained using cell
migration media containing ten (10) percent fetal calf
serum (FCS). Similar to our previous reports, laminin-5-
coated wells induced a greater than four-fold increase in
rVSMC migration over that measured in naked plastic
controls in three independent experiments as shown in
Figure 1 (n = 24, p < 0.05). Furthermore, PDGF-BB, tested
over a biologically relevant range of 5 – 50 ng/mL, stimu-
lated a dose-dependent increase in rVSMC migration on
laminin-5 (between 5 – 25 ng/mL), increasing migration
fifteen (15) to sixty (60) percent over laminin-5-stimu-
lated migration alone (n = 24, p < 0.005). This PDGF-BB-
stimulated increase in migration peaked at 25 ng/mL and
did not significantly increase over the range of 25 – 50 ng/
mL (data not shown).
The mitogen-activated protein kinase (MAPK) pathway is
known to be activated by PDGF-BB-stimulation in VSMC
[14]. To explore the mechanism of increased rVSMC
migration on laminin-5 via PDGF-BB-stimulation, we
used PD98059 which is a specific inhibitor of MEK1 and
MEK2, and a general inhibitor of MAPK activation. The
addition of PD98059 in concentrations between 10 – 50
ng/mL reduced PDGF-BB-stimulated migration on lam-
inin-5 (25 ng/mL) in a dose-dependent manner, reaching
a maximal reduction of sixty (60) to seventy (70) percent
over the range of 20 – 40 ng/mL, as shown in Figure 1 (nCell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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= 24, p < 0.005). This reduction in PDGF-BB-stimulated
migration on laminin-5 was maintained at all concentra-
tions of PDGF-BB tested (5 – 25 ng/mL).
To determine if this modulation is restricted to MEK/
MAPK-inhibition, we tested the effects of adding exoge-
nous transforming growth factor (TGF-β1) for its ability to
PDGF-BB increased rVSMC migration on laminin-5 in vitro Figure 1
PDGF-BB increased rVSMC migration on laminin-5 in vitro. The addition of PDGF-BB increased rVSMC migration on 
laminin-5, in a dose-dependent manner, over rVSMC haptotactic migration induced by the presence of laminin-5. rVSMC 
migration on laminin-5 was inhibited by both PD98059 (MEK1 inhibitor) and TGF-β1, in a dose-dependent manner.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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modulate the PDGF-stimulated increase in rVSMC
migration on laminin-5. Our results indicated that the
addition of TGF-β1 was able to reduce laminin-5-stimu-
lated rVSMC migration to levels approximating the levels
observed in naked plastic controls over all tested ranges (5
– 50 ng/mL), although the most statistically distinct
reduction was found over the range of 5 – 25 ng/mL, as
shown in Figure 1. In addition, TGF-β1 was able to reduce
maximal PDGF-BB-stimulated migration of rVSMC (25
ng/mL) on laminin-5 by approximately fifty (50) to sixty
(60) to percent, over the range of concentrations from 20
to 40 ng/mL.
Adhesion
To determine whether or not the PDGF-BB-stimulated
increase in rVSMC migration correlates with a reduction
in rVSMC adhesion to laminin-5, thirty-minute in vitro
adhesion assays were performed. In the absence of exoge-
nous growth factor stimulation, laminin-5- and fibronec-
tin-coated wells (20 µg/mL) sustained an approximate
two and a half-fold increase in rVSMC adhesion com-
pared with negative controls, as shown in Figure 2 (n = 24,
p < 0.05). The addition of PDGF-BB, at the maximal
migration-stimulating dose of 25 ng/mL, decreased the
adhesion of rVSMC on laminin-5 by more than sixty-five
(65) percent (n = 24, p < 0.005). The addition of exoge-
nous PDGF-BB (25 ng/mL), however, decreased rVSMC
adhesion on fibronectin by less than thirty (30) percent.
To investigate if the relationship between the PDGF-BB-
stimulated increase in migration and corresponding
decrease in adhesion of rVSMC on laminin-5 may be
related to MAPK activation, cells were pre-treated with
PD98059 (40 ng/mL) for twenty (20) minutes prior to
assay and the adhesion media was supplemented with
PD98059 (40 ng/mL). The addition of exogenous
PD98059 (40 ng/mL) restored the PDGF-BB-stimulated
reduction (25 ng/mL PDGF-BB) in rVSMC adhesion to
laminin-5, to approximately eighty-five (85) percent of
laminin-5 controls (n = 24, p < 0.05). The addition of
PD98059, however, did not restore the thirty (30) percent
PDGF-BB-stimulated reduction in rVSMC adhesion on
fibronectin.
To determine if this modulation is restricted to MEK/
MAPK-inhibition, we tested the effects of adding exoge-
nous transforming growth factor (TGF-β1). Our results
indicated that the addition of TGF-β1 (25 ng/mL) was
able to restore the PDGF-BB-stimulated reduction in
rVSMC adhesion on laminin-5 by roughly the same level
as PD98059, eighty two (82) percent versus eighty five
(85) percent, respectively. In contrast to PD98059, the
addition of TGF-β1 (25 ng/mL) was sufficient to restore
the PDGF-BB-stimulated reduction in rVSMC adhesion
on fibronectin.
Proliferation
Based upon our observations of rVSMC migration and
adhesion, we performed in vitro proliferation assays to
determine the relative effects of the extracellular matrix
(ECM) and exogenous growth factors described above.
First, to test the effects of the ECM substrate on rVSMC
proliferation in the absence of exogenous growth factors,
quiescent cells were plated in cell-culture plates either
coated with or without laminin-5 or fibronectin, in
serum-free Dulbecco's Modified Eagle's Medium (DMEM)
for one (1) to six (6) days.
To induce quiescence, rVSMC were incubated for forty
eight (48) hours without mitogen (0% FCS, FBS) at 37°C
and quiescence was verified by proliferation controls, cul-
tured for forty eight (48) hours at 37°C with mitogen
stimulus as shown in Figure 3a and 3b. Previous studies
with VSMC report that greater than 95% of cells incubated
in low-serum media (0.4% FCS or less) were arrested in
G0(G1) between forty eight (48) and seventy two (72)
hours as determined by flow cytometry and determina-
tion of [3H] thymidine-labeled nuclei [15].
Our results suggest that culture of rVSMC plated on exog-
enous laminin-5 (coated at a concentration of 20 µg/mL)
did not significantly increase cellular proliferation com-
pared with naked plastic controls over a period of four (4)
days, as shown in Figure 3a (n = 24, p < 0.02). Culturing
of rVSMC plated on exogenous fibronectin (coated at a
concentration of 20 µg/mL) however, did significantly
increase cellular proliferation over a period of four (4)
days by nearly two-fold, as shown in Figures 3a and 3b.
Next, to test the modulating effects of exogenous growth
factors on rVSMC proliferation when cultured on these
ECM substrates, quiescent cells were plated in cell-culture
plates either naked or coated with laminin-5 or fibronec-
tin, in the presence of TGF-β1 or PDGF-BB, both at a con-
centration of 25 ng/mL, from one (1) to six (6) days. Our
results indicated that the addition of exogenous TGF-β1
(25 ng/mL) to the cell culture medium was sufficient to
induce a suppressing effect on rVSMC proliferation on
naked plastic, as well as laminin-5 and fibronectin, to lev-
els approximating the quiescent growth controls.
The addition of PDGF-BB was sufficient to induce an
increase in rVSMC proliferation on laminin-5 of nearly
one-half (46%) over laminin-5 DMEM (no serum, no
mitogen) controls (n = 24, p < 0.01). However, our results
indicate that the addition of exogenous PDGF-BB (25 ng/
mL) did not have a statistically significant effect on cells
plated on fibronectin.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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PDGF-BB reduces rVSMC adhesion on laminin-5 adhesion in vitro Figure 2
PDGF-BB reduces rVSMC adhesion on laminin-5 adhesion in vitro. The presence of laminin-5 supported greater 
adhesion of rVSMC over naked plastic, and this increase in adhesion was reduced by the addition of PDGF-BB. Inhibition of 
MEK1, using PD98059 restored rVSMC adhesion to laminin-5 in the presence of PDGF-BB. Although fibronectin also sup-
ported rVSMC adhesion, the effect of adding PDGF-BB was less pronounced and was not restored using PD98059. The addi-
tion of TGF-β1, however, completely restored rVSMC adhesion to both fibronectin and laminin-5 in the presence of PDGF-BB.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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The effect of growth factors on rVSMC proliferation in vitro Figure 3
The effect of growth factors on rVSMC proliferation in vitro. The addition of PDGF-BB stimulated proliferation of 
rVSMC on laminin-5 and to some extent on naked plastic, but not on fibronectin. The presence of fibronectin alone was able 
to stimulate proliferation of rVSMC. The proliferative response of rVSMC to presence of laminin-5 with PDGF-BB or to 
fibronectin was suppressed by the addition of TGF-β1. Figure 3b The ECM induces differential rVSMC proliferation responses 
in vitro. The plating of rVSMC on fibronectin, but not laminin, induced increases in proliferation over four days. The addition of 
PDGF-BB, however, increased rVSMC migration on laminin-5, but not on fibronectin. The addition of TGF-β1 was sufficient to 
suppress rVSMC proliferation on both laminin-5 and fibronectin.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
Page 7 of 12
(page number not for citation purposes)
Mitogen Activated Protein Kinase (MAPK) Western Blot
To examine MAPK activation, rVSMC were plated onto
laminin-5- or fibronectin-coated plates, then lysed after
thirty minutes and prepared for immunoblotting. Our
results indicated that laminin-5 did not induce a detecta-
ble increase in MAPK activation over a thirty (30) minute
time interval, as shown in Figure 4. rVSMC plated on
fibronectin did exhibit a significant increase in MAPK lev-
els after thirty (30) minutes.
The addition of growth factors, such as PDGF-BB and
TGF-β1, have been associated with increases in p44/p42
(ERK1/2) or MAPK activation [16-18]. To determine the
effects of PDGF-BB and TGF-β1 on rVSMC, subconfluent
cell cultures were pre-treated with FCS (10%), PDGF-BB
(25 ng/mL) or TGF-β1 (25 ng/mL) for thirty (30) minutes,
then lysed and prepared for immunoblotting. p44/p42
phosphorylation levels were not detectable in DMEM-
treated control cells, as shown in Figure 4. However, the
The MAPK pathway in rVSMC is activated by different stimuli Figure 4
The MAPK pathway in rVSMC is activated by different stimuli. The addition of FCS or PDGF-BB or the plating of 
rVSMC on fibronectin was sufficient to induce measurable increases in p44/p42 activation over 30 minutes. However, the addi-
tion of TGF-β1 or the plating of rVSMC on laminin-5 was not sufficient to induce MAPK activation.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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addition of PDGF-BB, but not TGF-β1, was sufficient to
induce measurable increases in MAPK activation levels.
Discussion
PDGF-BB is an in vitro VSMC mitogen and may be respon-
sible for initiating the phenotypic changes in VSMC
migration and proliferation during restenosis in vivo
[19,20]. Our recent reports of low-level laminin-5 expres-
sion in the intima of normal arteries and increased expres-
sion in the neointima of injured arteries suggest that
laminin-5, in conjunction with soluble growth factors and
mitogens, may determine VSMC phenotype during reste-
nosis [11-13].
The current study augments the body of evidence that sug-
gests VSMC growth is influenced by an ECM-VSMC inter-
action [21] and that VSMC proliferation in different
species respond differently to growth factor stimulus [15].
More specifically, this study explores evidence that lam-
inin-5 and PDGF-BB may have combined and synergistic
effects in determining rVSMC phenotype in vitro [6,8,10].
More specifically, our studies suggest that PDGF-BB
strongly influences rVSMC behaviors such as migration.
In addition, PDGF-BB significantly alters other cellular
behaviors such as adhesion and proliferation on laminin-
5, but only to a lesser extent on fibronectin.
Because PDGF-BB stimulation increases the overall levels
of intracellular MAPK, as well as MAPK phosphorylation,
we sought to explore this signaling cascade to determine
its role in modulating these rVSMC behaviors on laminin-
5 [22]. Specifically, the ERK1/2 form of MAPK mediates
signaling by PDGF-AA, PDGF-AB, and PDGF-BB in VSMC,
as well as signaling through laminin-5 binding integrins,
and is therefore the most likely signaling molecule to
modulate these cellular behaviors [23-25]. Our results
suggest that rVSMC behaviors in vitro, driven by PDGF-BB
responsiveness, can be blocked by MAPK inhibition (via
MEK1 inhibitor: PD98059) on laminin-5, but not on
fibronectin.
An additional signaling regulator, TGF-β1, has been
implicated in the negative regulation and decreased rate
of proliferation of VSMC stimulated with serum or PDGF
[26-28]. Our results from this study indicate that TGF-β1,
unlike the MEK1-inhibitor PD98059, was sufficient to
block rVSMC behaviors on both laminin-5 and fibronec-
tin. Specifically, the addition of TGF-β1 was able to reduce
PDGF-BB-stimulated migration and proliferation of
rVSMC on both ECM substrates and was also able to
restore PDGF-BB-stimulated reductions in VSMC adhe-
sion on these ECM.
Several lines of evidence now suggest that the anti-
mitogenic effects of TGF-β1 may be dissociated from inhi-
bition of ERK1/2 signaling pathways [17,18]. These
reports suggest that TGF-β1 inhibition of PDGF-BB may
be temporally independent of other early signaling path-
ways, such as MAPK, and is more likely to block VSMC
behaviors, such as proliferation, by inhibiting events later
in the G1 phase of mitosis.
Although our previous reports linked ERK1/2 to rVSMC
adhesion and migration, these studies did not examine
the possibility for differential signaling initiated by
rVSMC binding to laminin-5 or fibronectin [12,13].
Expanding our original analysis of growth factor
stimulation of MAPK to include ECM binding reveals that
integrin binding of rVSMC to fibronectin strongly
increases detectable MAPK activation levels, as does FCS
and PDGF-BB stimulation, whereas binding to laminin-5
does not. These differences may help to explain the differ-
ing effects on cellular behaviors of binding to these ECM
ligands, as fibronectin and PDGF-BB may act in unison to
activate intracellular signaling cascades that converge in
MAPK activation, while laminin-5 may not.
Conclusions
Our results indicate that laminin-5 activates different
intracellular signaling pathways from those of fibronectin
and PDGF-BB in rVSMC and that binding to laminin-5
may modulate rVSMC behaviors that are distinctive from
those modulated by fibronectin. Although binding of
rVSMC to laminin-5 may not cause an initial increase in
MAPK activation levels or proliferation, laminin-5 can
augment PDGF-BB-stimulated proliferation and migra-
tion of rVSMC in vitro. Based upon these findings, we pos-
tulate that PDGF-BB and laminin-5 binding may initially
activate different intracellular signaling cascades, causing
rVSMC to be more responsive to the inhibition of MEK1
and MAPK on laminin-5 than those activated on fibronec-
tin, as outlined in Figure 5.
In contrast to laminin-5, fibonectin and PDGF-BB may
have parallel, reinforcing roles in MAPK activation. Our
analysis of the effects of TGF-β1 demonstrated that TGF-
β1 does not strongly activate MAPK in rVSMC, but rather
strongly inhibits the effects of fibronectin and PDGF-BB-
stimulation on laminin-5. Our results support the previ-
ous findings that TGF-β1 may inhibit mitogenesis and
other VSMC behaviors via mechanisms independent of
MAPK activation.
These results suggest that a clear understanding of the
roles and contributions of each ECM may provide new
insights into the mechanisms of regulating rVSMC cell
behaviors, including migration, adhesion, and prolifera-
tion. Further analysis of the events that trigger and sustain
the underlying cellular mechanisms of rVSMC behaviorsCell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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Integrins and growth factors activate intracellular signaling cascades in rVSMC Figure 5
Integrins and growth factors activate intracellular signaling cascades in rVSMC. Intracellular signaling pathways that 
converge through MEK and ERK activation, may be initiated in rVSMC by the addition of PDGF-BB, as well as binding to lam-
inin-5 or fibronectin. The MEK1 inhibitor PD98059 blocks MEK1 activation and alters rVSMC responses to PDGF-BB on lam-
inin-5, but not fibronectin. The addition of TGF-β1, which may block later events in the cell cycle, is sufficient to block PDGF-
BB induced responses of rVSMC on both laminin-5 and fibronectin.Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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may help aid in the design of more effective therapies for
the treatment of restenosis.
Methods
Cell culture
Cells were maintained in 100 mm × 20 mm Corning tis-
sue-culture dishes (Plainfield, NJ) at 37°C and 5% CO2 in
humidified chambers. Cells were maintained in DMEM
High Glucose, supplemented with 10% fetal bovine
serum and 1% L-glutamine (29.2 mg/mL), penicillin G
(10,000 U/mL), and streptomycin sulfate (10,000 mcg/
mL) (GPS) from Irvine Scientific (Santa Ana, CA). Rat aor-
tic smooth muscle cell explants were a gift from RC Smith
and were isolated and passaged as previously described
[29]. Although greater than 95% quiescence, G0(G1) arrest
can routinely be induced by incubation of cells for 72 h.
in low-mitogen (0.5% FBS) medium [15,30], these
authors suggest that incubation of VSMC for 48 h. without
mitogen (0% FBS) is sufficient to induce quiescence. This
was verified by proliferation control cells, cultured for 48
h. at 37°C with and without mitogen stimulus.
Migration assays
Cell migration assays were performed in Costar transwell
filter plates either coated with purified matrix (laminin-5
or fibronectin) at a protein concentration of 20 µg/mL for
one hour (60 min.) at room temperature, 25°C, and
washed twice with phosphate-buffered saline 0.2%
Tween-20 and 5% skim milk (PBST) prior to assay as pre-
viously described [31,32]. Cells were seeded at a concen-
tration of 1.2 × 105 in each of 96-transwell chamber filters
(100 µL of 1.2 × 106 cells/mL solution) with and without
ECM in the presence or absence of PDGF-BB at the indi-
cated concentrations (5–25 ng/mL) and allowed to
migrate for 18 hours at 37°C. Where applicable, the
medium was supplemented with PD98059 (MEK1-inhib-
itor) at the indicated concentration. Cells were counted at
the end of an 18-hour interval as indicated, quantified
with the following modification. 30 minutes prior to
measuring migration, 5 µM calcein AM from Molecular
Probes (Eugene, OR) was added to the migration wells at
37°C. To quantitate migration, cells were removed from
the top of the filter with cotton-tipped applicators and flu-
orescence of the incorporated calcein was measured from
the bottom of the filter with a fluorescence plate reader.
Relative fluorescence values for each experimental condi-
tion are expressed relative to controls and untreated
samples.
Adhesion assays
Cell adhesion assays were performed as previously
described [31,32] using Costar 96-well cell culture cluster
plates, coated with either laminin-5 or fibronectin solu-
tion at a protein concentration of 20 µg/mL for 1 hour (60
m i n . )  a t  r o o m  t e m p e r a t u r e ,  2 5 ° C .  W e l l s  w e r e  t h e n
washed twice with PBST prior to assay. Cells were seeded
at a concentration of 1.2 × 105 in each of 96-transwell
chamber filters (100 µL of 1.2 × 106cells/mL solution)
with and without ECM-coating (described above) in the
presence or absence of PDGF-BB (25 ng/mL), TGF-β1 (25
ng/mL), or both, and allowed to attach for 30 minutes at
37°C. Where applicable, cells were first incubated for 20
minutes with PD98059 (40 ng/mL), a MEK1 inhibitor
from New England Biolabs (Beverly, MA) at 37°C and the
adhesion assay culture medium was supplemented with
PD98059 at 40 ng/mL. Following adhesion, non-adher-
ent cells were removed by suspending plates upside down
in a rotating tank of PBS for 10 minutes at room temper-
ature, 25°C. Adherent cells were then fixed and stained
and the relative absorbance was measured using a TECAN-
SPECTRAFluor spectrophotometer (TECAN, Durham,
NC) at 595 nm.
Proliferation assays
Tissue culture plates were coated with purified fibronectin
from Calbiochem (La Jolla, CA) or laminin-5 from
Demos (La Jolla, CA) at a 20 µg/mL protein concentration
for 1 hour (60 min.) at room temperature, 25°C as previ-
ously described [31]. Cells were seeded at a concentration
of 1.2 × 105 in 100 mm2 cell culture plates with and with-
out fibronectin or laminin-5 and allowed to attach over-
night (12 h.) at 37°C. Cells were then starved in serum-
free DMEM for 48 hours to induce quiescence at 37°C, as
outlined in Cell Culture Methods below. The medium was
then replaced with fresh medium containing 25 ng/mL of
TGF-β1 or PDGF-BB obtained from Calbiochem (La Jolla,
CA) and incubated at 37°C. Cells were removed from cul-
ture wells with trypsin/EDTA and counted using trypan
blue stain from Gibco Life Technologies (Rockville, MD)
and a VWR Scientific Counting Chamber (Plainfield, NJ)
at 24 hour intervals, from 1 – 6 days.
Western Blot analysis
Quiescent VSMC were pre-treated with culture medium
containing 10% FCS, PDGF-BB (25 ng/mL), TGF-β1 (25
ng/mL), or plated on laminin-5- or fibronectin-coated tis-
sue culture plates with DMEM for 30 minutes at 37°C.
Subconfluent cell cultures were then lysed using ice-cold,
1X lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, 1.0% Triton X-100, pH 7.5) and boiled in SDS
Boiling Buffer prior to analysis as previously described
[33]. Proteins were separated by 7.5% SDS-PAGE and
transferred to Immobilon-P transfer membranes from
Millipore (Bedford, MA), incubated with primary anti-
body (1:200 dilution at 4°C overnight, 12 h.), secondary
antibody (1:2000 dilution at 25°C for 1 h.), and then
exposed to NEN CDP-Star chemiluminescence reagent
(5–7 min.) and developed on Kodak X-OMAT LS scien-
tific imaging film for subsequent analysis. Antibodies
used for this analysis were anti-phospho ERK (p42/p44)Cell Communication and Signaling 2005, 3:2 http://www.biosignaling.com/content/3/1/2
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rabbit polyclonal IgG primary antibody and goat anti-rab-
bit IgG-AP secondary antibody from Santa Cruz Biotech-
nology (Santa Cruz, CA).
Statistics
The differences between untreated and treated cell popu-
lations were measured using a t distribution. All samples
were measured using two-tailed t tests as departure from
normality can make more of a difference in a one-tailed
than in a two-tailed t test. So long as the sample size is
even moderate (>20) for each group, quite severe depar-
tures from normality make little practical difference in the
conclusions reached from these analyses [34].
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